Information:
|
The Biomedical Research Integrated Domain Group (BRIDG) Project is a collaborative effort engaging stakeholders from the Clinical Data Interchange Standards Consortium (CDISC), the HL7 Regulated Clinical Research Information Management Technical Committee (RCRIM TC), the National Cancer Institute (NCI) and its Cancer Biomedical Informatics Grid (caBIG), and the US Food and Drug Administration (FDA). The goal of the BRIDG Project is to developed a shared view of the data, relationships, and processes which collectively define the domain of protocol-driven research. Specifically, the formal definition of the domain-of-interest for the BRIDG Project stakeholders is: Protocol-driven research, i.e. the data, organization, resources, and processes involving the assessment of the utility, impact, or other pharmacological, physiological, or psychological effects of a drug, procedure, process, or device on a human, animal, or other biologic subject or substance plus all associated regulatory artifacts required or derived from said research.
A shared view of the various structures and processes that define the BRIDG domain is essential in achieving the larger goal of computable semantic interoperability (CSI) both among people and systems within the domain as well as between those working within and those working outside the domain (e.g. healthcare institutions.)
(Automatically extracted from the Health Level 7 OID Registry)
|
|